Literature DB >> 34954379

Hedgehog signaling underlying tendon and enthesis development and pathology.

Fei Fang1, McKenzie Sup2, Andrew Luzzi1, Xavier Ferrer1, Stavros Thomopoulos3.   

Abstract

Hedgehog (Hh) signaling has been widely acknowledged to play essential roles in many developmental processes, including endochondral ossification and growth plate maintenance. Furthermore, a rising number of studies have shown that Hh signaling is necessary for tendon enthesis development. Specifically, the well-tuned regulation of Hh signaling during development drives the formation of a mineral gradient across the tendon enthesis fibrocartilage. However, aberrant Hh signaling can also lead to pathologic heterotopic ossification in tendon or osteophyte formation at the enthesis. Therefore, the therapeutic potential of Hh signaling modulation for treating tendon and enthesis diseases remains uncertain. For example, increased Hh signaling may enhance tendon-to-bone healing by promoting the formation of mineralized fibrocartilage at the healing interface, but pathologic heterotopic ossification may also be triggered in the adjacent tendon. Further work is needed to elucidate the distinct functions of Hh signaling in the tendon and enthesis to support the development of therapies that target the pathway.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Development; Fibrocartilage; Growth plate; Healing; Hedgehog signaling; Heterotopic ossification; Mineralization; Tendon enthesis

Mesh:

Substances:

Year:  2021        PMID: 34954379      PMCID: PMC8821161          DOI: 10.1016/j.matbio.2021.12.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  141 in total

1.  BMP signaling stimulates chondrocyte maturation and the expression of Indian hedgehog.

Authors:  C D Grimsrud; P R Romano; M D'Souza; J E Puzas; E M Schwarz; P R Reynolds; R N Roiser; R J O'Keefe
Journal:  J Orthop Res       Date:  2001-01       Impact factor: 3.494

2.  Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification.

Authors:  M C Eddy; S M Jan De Beur; S M Yandow; W H McAlister; E M Shore; F S Kaplan; M P Whyte; M A Levine
Journal:  J Bone Miner Res       Date:  2000-11       Impact factor: 6.741

Review 3.  Building drug delivery into tissue engineering.

Authors:  W Mark Saltzman; William L Olbricht
Journal:  Nat Rev Drug Discov       Date:  2002-03       Impact factor: 84.694

4.  Enthesis fibrocartilage cells originate from a population of Hedgehog-responsive cells modulated by the loading environment.

Authors:  Andrea G Schwartz; Fanxin Long; Stavros Thomopoulos
Journal:  Development       Date:  2015-01-01       Impact factor: 6.868

5.  Potent small molecule Hedgehog agonists induce VEGF expression in vitro.

Authors:  Katrin Seifert; Anita Büttner; Stephan Rigol; Nicole Eilert; Elke Wandel; Athanassios Giannis
Journal:  Bioorg Med Chem       Date:  2012-08-28       Impact factor: 3.641

6.  Smoothened antagonists reverse taxane resistance in ovarian cancer.

Authors:  Adam D Steg; Ashwini A Katre; Kerri S Bevis; Angela Ziebarth; Zachary C Dobbin; Monjri M Shah; Ronald D Alvarez; Charles N Landen
Journal:  Mol Cancer Ther       Date:  2012-05-02       Impact factor: 6.261

7.  Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation.

Authors:  B St-Jacques; M Hammerschmidt; A P McMahon
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

8.  Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway.

Authors:  Xu Wu; John Walker; Jie Zhang; Sheng Ding; Peter G Schultz
Journal:  Chem Biol       Date:  2004-09

9.  Teratogen-mediated inhibition of target tissue response to Shh signaling.

Authors:  M K Cooper; J A Porter; K E Young; P A Beachy
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

Review 10.  Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.

Authors:  Joseph A Clara; Cecilia Monge; Yingzi Yang; Naoko Takebe
Journal:  Nat Rev Clin Oncol       Date:  2019-12-02       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.